Race to shield kidneys during High-Risk cancer procedure
NCT ID NCT07229040
Summary
This study aims to see if one drug (cilastatin) works as well as another (thiosulfate) at protecting the kidneys during a specific, intensive surgery for ovarian cancer. The surgery involves removing visible tumors and then bathing the abdomen with heated chemotherapy. Researchers will enroll 90 adult female patients and measure kidney function for up to two weeks after the procedure to compare the drugs' effectiveness.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE KIDNEY INJURY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hodpsital General Universitario Gregorio Marañón
RECRUITINGMadrid, Madrid, 28007, Spain
Contact Email: •••••@•••••
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.